Clinical Trials

Enrolling clinical trials

Acne Vulgaris (Acne) Moderate to Severe

Pediatric Acne Vulgaris (Acne) Mild to Severe

Upcoming Clinical Trials

• Actinic Keratosis (Rough Scaly Patches)

• Atopic Dermatitis (Itchy Inflamation)

• Plaque Psoriasis (Scaly Rash)

Pruritus (Itch)


Completed clinical trials

  • A split face, double-blind, randomized clinical trial of the effects of XXX using two applications per day to the half face for 3 months followed by 2 applications per day to the whole face for 3 months
  • • The P.U.M.P Study:  Patients using MICRO properly; an open-label, community based, phase IV study to assess facial acne improvement with the use of XXX microsphere, 0.04% or 0.1% in a pump dispenser
  • A Phase III, randomized, placebo-controlled, multi-center, double-blind study of the safety and duration of efficacy of XXX in correction of moderate to severe glabellar lines (and including a sub-study to detect any treatment-related QT interval changes)
  • A multi-center, Phase 3, randomized, double-blind, clinical trial to compare the safety and efficacy XXX vs. YYY in the treatment of acne vulgaris
  • Protocol C-05-16 Treatment of the upper arms using XXX
  • To demonstrate the ability of XXX to improve the cosmetic appearance of post laser scar removal
  • Open-label, randomized, split-face study to evaluate the efficacy, safety and subject satisfaction of pain management during and after XXX dermal filler injections for the correction of nasolabial folds
  • A phase ¾ multi-center, open-label extension study to assess the long-term safety of repeat administrations of XXX in the treatment of glabellar lines
  • A prospective, randomized, double-blind, placebo controlled, multicenter trial to investigate the efficacy and safety of XXX, free of complexing proteins, in the treatment of glabellar frown lines
  • A Randomized, evaluator blinded, no treatment controlled study of the effectiveness and safety of XXX in the augmentation of soft tissue fullness of the lips
  • A double-blinded, randomized, split-face study to evaluate the efficacy, safety and subject satisfaction of pain management utilizing XXX in a novel nano technology delivery system vs. YYY during and after ZZZ dermal filler injections for correction of nasolabial folds
  • An open-label randomized, split-face study to evaluate the efficacy, safety and subject satisfaction of a novel contact XXX for the pain management as well as ecchymosis during and after YYY dermal filler injections for the correction of nasolabial folds
  • A prospective, open-label, multicenter, repeat-dose trial to investigate the safety and efficacy of XXX, free of complexing proteins, in the treatment of glabellar frown line
  • A Randomized, Double-Blind, Clinical Study Designed to Assess the Onset, Efficacy and Safety of XXX versus YYY in the Treatment of Dynamic Rhytids of the Frontalis (Individual Subject Contalateral Injection Sites) Utilizing the Objective Frontalis Activity Measurement StandardTM
  • A multi-site clinical study designed to assess and document a new fat harvesting and autologous fat grafting procedure
  • A randomized double-blind, vehicle-controlled pilot study to assess the efficacy of XXX formulated in a novel delivery system in the treatment of moderate to severe acne vulgaris
  • A randomized double-blind, vehicle-controlled pilot study to assess the efficacy of XXX formulated in a novel nano technology delivery system in the treatment of moderate to severe Melasma
  • Double-Blind Randomized Sham Controlled Trial to Evaluate the Effect of 635 nm LLLT on Circumference Reduction of the Upper Arms
  • A randomized double-blind vehicle-controlled pilot study to assess the efficacy of topically applied XXX, YYY, and ZZZ in the treatment of hyperhidrosis using a novel transdermal delivery system
  • Evaluation of the safety and efficacy of the XXX System for treatment of axillary hyperhidrosis
  • A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of XXX in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
  • A randomized, evaluator-blinded, no-treatment-controlled study of the effectiveness and safety of XXX in the correction of midface volume deficit and/ or midface contour deficiency
  • A randomized double-blind, vehicle-controlled study to assess the efficacy of XXX formulated in a novel nano technology delivery system in the treatment of moderate Papular and Pustular Acne
  • A phase 3 randomized, double-blind, 12-week vehicle-controlled, parallel-group study assessing the efficacy and safety of XXX versus vehicle cream in subjects with papulopustular rosacea, followed by a 40-week investigator blinded extension comparing the long-term safety of XXX versus YYY
  • A randomized, evaluator-blinded, no treatment, controlled study of the effectiveness and safety of XXX in the augmentation of soft tissue fullness of the lips.
  • Histological Evaluation of Sweat Glands in Axillary Hyperhidrosis Subjects After Treatment with the XXX System
  • A Prospective, parallel, randomized, sham-controlled, blinded pilot trial of the safety and efficacy of the XXX system for treatment of axillary hyperhidrosis
  • A double-blind, placebo-controlled randomized evaluation of the effect of the XXX on body contouring of the waist, hips and thighs five-day treatment protocol
  • Treatment of Facial Actinic Keratosis with XXX or YYY with and without Prior Treatment with XXX
  • A sequential treatment regimen of Cryotherapy and XXX field therapy compared to cryotherapy alone for the treatment of Actinic Keratosis on the face and scalp
  • A Multi-center, double-blind, randomized, vehicle-controlled, parallel-group study comparing XXX  to the referenced listed YYY and both active treatments to a vehicle control in the treatment of Acne Vulgaris
  • A parallel-group, vehicle-controlled, randomized, double-blind study of the efficacy and safety of XXX and YYY in subjects with seborrheic dermatitis
  • A prospective, multi-center, parallel, randomized, double-blinded study of the efficacy and safety of the XXX system for the treatment of primary Axillary Hyperhidrosis
  • A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Evaluating the Safety and Efficacy of XXX in the Aesthetic Treatment of Disproportionate Abdominal Bulging Due To Excess Subcutaneous Fat in Healthy, Non-Obese Patients
  • A 3-Day Investigator Blinded, Randomized Study Evaluating XXX Versus Untreated Control in the Treatment of Atopic Dermatitis Associated Pruritus
  • A Randomized, Vehicle-Controlled, Double-Blind, Parallel Group, Multi-Center Phase III Study to Evaluate the Safety and Efficacy of XXX in Subjects with Plaque Psoriasis
  • A Randomized, Double-Blind, Contralateral, Controlled Study to Assess the Efficacy of XXX Formula in Improving the Appearance of Chronically Aged Mature Skin of the Forearms and Hands
  • Evaluation of the Safety and Efficacy of Oral Polypodium Leucotomos Extract in Healthy Adult Subjects
  • A Multi-Center, Prospective, Randomized, Double-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of XXX on the Outcome of Scar Revision Surgery on Transverse Hypertrophic Scars on the Lower Abdomen Resulting from Previous Surgeries in Healthy Adults
  • A Multicenter Safety and Efficacy Study to Compare XXX with Vehicle Control in Patients with Acne Vulgaris
  • A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of XXX on the Outcome of Keloid Excision Surgery in Healthy Adults
  • Safety and efficacy of escalating doses of XXX once daily for two or three consecutive days when used on full face, full balding scalp or approximately 250 cm2 on the chest in subjects with actinic keratosis
  • A Phase 3 Study of Photodynamic Therapy with XXX + YYY + ZZZ For The Treatment of Actinic Keratoses On The Upper Extremities
  • A Randomized Five Week Dose-Comparison Efficacy Pilot Study Of 1.0%, 5.0%, And 10.0% Topical Polypodium Leucotomos Formulated With A XXX, In The Reduction Of UVB Associated Erythema
  • A Clinical Study to Evaluate the Efficacy and Tolerance of Three Regimens in the Treatment of Mild to Moderate Acne Vulgaris
  • A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of XXX for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects
  • A multi-center, open label, multiple dose, phase II trial to demonstrate the safety of XXX in adult subjects for treatment of moderate-to-severe glabellar lines
  • A Multi-Center Randomized, Double-Blinded, Vehicle Contolled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of XXX and YYY in Subjects with Actinic Keratoses on the Trunk or Extremities
  • Efficacy and Safety of XXX in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest
  • A Double-Blind Placebo-Controlled Randomized Four-Week Study to Evaluate the Efficacy of XXX to Reduce Pruritus and Improve Quality of Life in Older Aged Adults
  • A Multicenter, Randomized, Double Blind, Vehicle-Controlled Study to Evaluate the Safety and the Effect on Sweat Production of 3 Concentrations of Topically Applied XXX in Subjects with Axillary Hyperhidrosis
  • A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of XXX Versus Vehicle Cream In  Subjects With Acne Vulgaris
  • A Prospective, Masked, Controlled Feasibility Study of the Method for Measuring Facial Lift Following Treatment with XXX
  • Split-Face Evaluation of the Efficacy and Tolerance of Daily Usage of Two Acne Light Therapy Wand Devices on Individual Inflammatory Lesions in Subjects with Mild to Moderate Inflammatory Acne
  • A Randomized Five Week Dose-Comparison Efficacy Pilot Study Of 0.1% And  0.5% XXX Formulated With A Transdermal Delivery System In The Reduction Of UVB Associated Erythema
  • A Single Center, Clinical Study to Evaluate the Efficacy and Tolerance of Three Skincare Regimens in the Treatment of Mild to Moderate Acne Vulgaris
  • Efficacy and Safety of XXX in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
  • An Observer Blinded, Randomized Study to Determine the Safety and Efficacy of a XXX Versus YYY for the Appearance of Surgical Scars
  • • Safety of XXX 0.018%, 0.037% and 0.1% for actinic keratosis applied once daily for three consecutive days on face/chest, scalp and trunk/extremities, respectively.

  • Last Updated 10/13/2016